Bruker Corp (FRA:BKD)
€ 60.6 1.32 (2.23%) Market Cap: 9.12 Bil Enterprise Value: 10.17 Bil PE Ratio: 23.63 PB Ratio: 6.67 GF Score: 93/100

Bruker Corp at Jefferies Healthcare Conference (Virtual) Transcript

Jun 02, 2021 / 12:00PM GMT
Release Date Price: €56 (-1.75%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

All right. Good morning, and thanks for joining us. Welcome to the Jefferies 2021 Virtual Global Healthcare Conference. I'm Brandon Couillard. I cover the life science tools in diagnostics sector here at the firm. It is my great pleasure to have Bruker with us at the conference again this year.

Joining us from the company today, Chairman, President and CEO, Dr. Frank Laukien; as well as Juergen Srega, who heads up the Bruker CALID Group. I'll turn it over to Frank to make some opening remarks, and then we'll jump into Q&A. Frank?

Frank H. Laukien
Bruker Corporation - Chairman, CEO & President

Yes, Brandon, great to be back. And with Juergen again, almost every year, we do that. Normally, it's ASMS time around the time of the Jefferies Healthcare Conference. This year, the big Mass Spectrometry Conference was pushed to the fall, but we nevertheless launched some very important products for proteomics yesterday, and I'll talk about that in a moment. And of course, that's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot